Dr.Gh.Hezareh Advisory Committee for Hospital Pharmacy.

Slides:



Advertisements
Similar presentations
EXPOSURE TO ANTINEOPLASTIC AGENTS IN THE PHARMACY LABORATORY SETTING AND ONGOING NIOSH STUDIES THOMAS H. CONNOR, Ph.D. Senior Service Fellow National Institute.
Advertisements

Introduction to IV Admixture and Aseptic Technique
ASEPTIC TECHNIQUE. PERSONAL PROTECTIVE EQUIPMENT includes: Eye protection Gloves Masks Gowns Sterile technique is employed to prevent contamination of.
Containment Equipment and Facilities. Biocontainment The principle of holding or being capable of holding or including within a fixed limit or area The.
Safety Training Presentation
Airflow and BSC Biosafety and Biosecurity Awareness Training
Randy Grekowicz,RPh; MBA Suzanne Lee, Pharm.D; RPh
Chemical Safety. Overview Chemical hazard classes Communication of hazards Routes of exposure Hierarchy of controls Special laboratory hazards.
Noha Mahmoud Lecturer of Clinical Pharmacy. Course Description This course is one credit hour course given during level 1. It gives idea about pharmacy,
Copyright ©2009 by Pearson Education, Inc. Upper Saddle River, New Jersey All rights reserved. The Pharmacy Technician: Foundations and Practices.
Prepared by Farid Khalaf.  Protect the worker.  Protect the sample being analyzed.  Protect the environment.
January 16, 2010 Monica Robinson Green, PharmD, BCPS.
 Molecular Laboratory must have an ongoing Bio-safety SOP and also quality improvement program to monitor and evaluate objectively and systematically.
Parenterals: Compounding Sterile Formulations Chapter 9 Start Quiz.
/0403 Copyright © 2004 Business & Legal Reports, Inc. BLR’s Safety Training Presentations Metalworking Fluids.
Sterile Preparation and Admixture Programs
Sterile & Parenteral Preparations
MCC PRESENTATION - GMP MANUFACTURING ENVIRONMENTS
NORTH AMERICAN SAFETY CHECKLIST – SB 158. Rhonda Anderson, RHIA President Anderson Health Information Systems, Inc. Presented By:
Medication Reconciliation in the Medical Floor A Patient Safety Quality Improvement Initiative Medication reconciliation is defined as a formal process.
SAFETY OBJECTIVE Without reference, identify basic facts about hospital safety practices pertaining to biological, chemical and fire hazards with at.
Sterile preparation Facilities and Equipment Biological Safety Cabinet
Dispensing to in and out patients or Drug distribution system
Infection Control Clinical Pharmacy and Patient Safety
Key Terminology 2 Practicum of Health Science – Pharmacy Tech Program.
Services and Supplies to Meet USP Requirements Patricia C. Kienle, RPh, MPA, FASHP Director, Accreditation and Medication Safety Cardinal Health Pharmacy.
INJECTABLES Nora A. Alkhudair. Injections Percutaneous introduction of a medicinal substance, fluid or nutrient into the body. (e. g. intradermal, subcutaneous,
Compounding Issues in Neuromodulation December 9, 2012 North American Neuromodulation Society 16 th Annual Scientific Meeting Wynn Hotel, Las Vegas Nevada.
12/12/ |1 | اداره كنترل سل و جذام نشست سالانه برنامه كنترل سل مازندران - بابلسر.
Safe Chemical Handling
Aseptic Technique Pharmacy Technician L.W. Higgins High School Spring 2010.
1 Summary of USP 797 for Compounding Sterile Preparations Presented at: HFMADV Meeting February 3, 2009 Presented by: Tom N. Petersen, P.E. Environmental.
Welcome to Nelson Laboratories This tour will help you understand the various tests that are performed here. There are 13 labs that complete testing using.
AIA Guidelines for Design and Construction of Hospital and Healthcare Facilities Presented By: Michael A. Rogers, PE
BLR’s Safety Training Presentations
Managing Hospital Safety: Common Safety Concerns Part 1 of 4.
1 Chemical and Biological Agents. 2 Introduction  Most occupational diseases such as asbestosis, silicosis, various types of dermatitis, spills, and.
Smallpox Vaccine Administration  Learning Objectives Demonstrate appropriate vaccine administration techniques Demonstrate appropriate vaccine administration.
Introduction to nuclear medicine technology NMT 231.
PHARMACY IV ADMIXTURE Pharmacy 483 January 18, 2005 Kim Donnelly Affiliate Associate Professor.
Update on Compounding Pharmacy Engineering Controls and
Advanced Nursing Skills Unit 4 Asepsis Absence of infection Freedom from germs 2 types of asepsis: Medical Surgical.
The Pharmacy Technician
sterile environment institutional pharmacy--- 18% of CPhT workers.
Course Code: NUR 240 Lecture ( 3). 1.The Risk of Infection is always Present in every Hospital. 2.Identify frequency of nosocomial infection.
ASEPTIC TECHNIQUE IN HEALTHCARE. MICROBIAL GROWTH FOLLOWING FACTORS INFLUENCE MICROBIAL GROWTH: TEMPERATURE PH, OR THE VALUES USED IN CHEMISTRY TO EXPRESS.
 Verify appropriateness of compound  Dose check, drug interactions  Is it commercially available?  Is there a formula available?  Is the BUD acceptable.
Infection Control Risk Assessment Guidelines and Standards Richard Vogel - Infection Control Specialist.
Sterile Products Lab PHT 434
Working safely with Biological materials Aseptic technique, sterilization and tissue culture techniques.
DRUG DISTRIBUTION SYSTEM Dispensing to In-Patients
Parenteral Preparations.  Sterile products are dosage forms of therapeutic agents that are free from micro-organisms or their spores.
Parenteral Admixture & Incompatibility
USP 800 Implementation in a Community Oncology Practice
Safelab Module 2 Biosafety Barry Byrne.
USP 797 Guidelines: Compounding Areas and Equipment
洗手及 负压技术 余 波
Author: Nurul Azyyati Sabri
Quality Control and Assurance
15 Introduction to Sterile Products.
sterile environment institutional pharmacy--- 18% of CPhT workers.
PHARMACY TECHNICIAN CHAPTER ELEVEN.
Parenteral Admixture & Incompatibility
USP 797 & USP 800: Updates Are Coming… Are You Prepared?
Parenterals: Compounding Sterile Formulations
OVERALL INFECTION PREVENTION SCORECARD
Sterile Products Lab PHT 434
Biosafety Principles: Separation, Seclusion & Containment
Hospital pharmacy el 2189 lab 1
Presentation transcript:

Dr.Gh.Hezareh Advisory Committee for Hospital Pharmacy

“Some problems are so complex that you have to be highly intelligent and well informed just to be undecided about them.” Dr. Laurence J. Peter

 Enteral  Parenteral  Contamination o Chemistry, PH, Sterility, Pyrogenisity, Potency, Appearance, Particular Matter  Sterility  Compounded Sterile Preparations (CSP)

1. Intended Use o Product quality (“5 Rights”) Right Patient, Right Medication, Right Dose, Right Time and Right Route 2. “Protect the product” o Sterility of compounded sterile preparation (CSP) through various methods 3. “Protect the worker”

Preventing harm due to: 1. Microbial contamination 2. Excessive bacterial endotoxins 3. variability in the intended strength 4. Unintended chemical and physical contaminants 5. ingredients of inappropriate quality in compounded CSPs

 Workers (the most common) o Contact o Skin, hair  Air o Air conditioning  Adjacent areas  Internal production o Walls, ceiling, floor, instruments

 Infection  Air Emboli  Allergy  Incompatibility  Particulate matters  Pyrogens

 Unable to eat or drink  Lake of absorption  Emergency  Lake of appropriate non-parenteral form

 Billions of compounded doses prepared annularly by pharmacists and other clinicians  More than 40% of inpatients receive CSPs  CSPs prepared under controlled conditions (pharmacists) and uncontrolled conditions (on the ward) by nurses and physicians  61% nurses malpractice

 Primary Engineering Controls (PEC)  Secondary Engineering Controls (SEC)  Filtration  Air Flow  Exhaust  Air Pressurization  Containment

Laminar Air Flow Workbench Barrier Isolator Biologic Safety Cabinet (BSC)